In 2013, the concept that cancer cells overexpress the transsulfuration enzyme cystathionine β-synthase (CBS) and use its enzymatic product, hydrogen sulfide (H2S), was formulated, first in colon cancer [1] and subsequently in ovarian cancer [2]. This evidence concerns the gene CBS and cancer.